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ab proteins amplify and integrate signals stimu-
lated by many growth factors. In culture and
animals, retinoic acid (RA) induces neuronal
differentiation. We show that Gab2 expression is de-
tected in neurons in three models of neuronal differentia-
tion: embryonic carcinoma (EC) stem cells, embryonic
stem cells, and primary neural stem cells (NSCs). RA
treatment induces apoptosis, countered by basic FGF
(bFGF). In EC cells, Gab2 silencing results in hypersensitiv-
ity to RA-induced apoptosis and abrogates the protection
by bFGF. Gab2 suppression reduces bFGF-dependent
G
 
activation of AKT but not ERK, and constitutively active
AKT, but not constitutively active MEK1, reverses the hy-
persensitization. Thus, Gab2-mediated AKT activation is
required for bFGF’s protection. Moreover, Gab2 silenc-
ing impairs the differentiation of EC cells to neurons.
Similarly, in NSCs, Gab2 suppression reduces bFGF-depen-
dent proliferation as well as neuronal survival and pro-
duction upon differentiation. Our ﬁndings provide the
ﬁrst evidence that Gab2 is an important player in neural
differentiation, partly by acting downstream of bFGF to
mediate survival through phosphoinositide 3 kinase–AKT.
 
Introduction
 
FGFs are peptide growth factors playing critical roles in various
cellular processes including cell proliferation, differentiation,
and survival. Among these, basic FGF (bFGF) is required for
normal cortex development (Dono et al., 1998). FGFs mediate
their actions through four different cell surface receptors, the
FGF receptors (FGFRs; Reuss and von Bohlen und Halbach,
2003). Ligand binding induces FGFR dimerization and auto-
phosphorylation on multiple tyrosine residues in its cytoplas-
mic domain. The phosphorylated tyrosines serve as docking
sites for SH2 domain–containing effectors including PLC
 
 
 
 and
Crk. A major downstream mediator is the PTB domain–con-
taining protein FRS2, which binds to FGFR and the NGF re-
ceptor in a phosphotyrosine (PY)-independent manner. Several
tyrosine residues in the COOH terminus of FRS2 are phos-
phorylated by activated FGFR or NGF receptors and serve to
recruit the adaptor protein Grb2 (Kouhara et al., 1997). FRS2
also regulates the phosphoinositide 3 kinase (PI3K)–AKT
pathway through its interaction with Gab1, with Grb2 as an
intermediate (Ong et al., 2001).
Gab1 belongs to an adaptor family consisting of Gab1,
Gab2, and Gab3 in mammals, the 
 
Drosophila melanogaster
 
orthologue Daughter of Sevenless (DOS), and the 
 
Caenorhabditis
elegans
 
 orthologue Suppressor of Clear (Soc 1). These proteins
share a highly conserved NH
 
2
 
-terminal pleckstrin homology
(PH) domain, a central proline-rich domain, and multiple ty-
rosine residues that are recognized by SH2 domain–containing
proteins. Gab proteins function downstream of multiple recep-
tors, such as the receptors for EGF, hepatocyte growth factor,
and FGF (Gu and Neel, 2003). Gab1 is expressed ubiquitously,
whereas Gab2 and Gab3 expression are more restricted. Al-
though the three mammalian Gabs share significant homology,
they are not functionally redundant. Gab1
 
 
 
/
 
 
 
 mice are embry-
onically lethal due to developmental defects in the heart, pla-
centa, and skin (Itoh et al., 2000). Gab2
 
 
 
/
 
 
 
 mice are viable
but show specific defects in allergic responses (Gu et al.,
2001). Finally, Gab3
 
 
 
/
 
 
 
 mice are reportedly normal (Seiffert
et al., 2003). Gab1 directly associates with c-Met, Grb2, SHP2,
and the p85 subunit of PI3K (Gu and Neel, 2003) and is impor-
tant for cell survival (Holgado-Madruga et al., 1997). Gab2
was cloned as an SHP2 interacting protein and binds to many
of the same proteins as Gab1. It functions in many cellular pro-
cesses, including differentiation, migration (W.M. Yu et al.,
2002), transformation (Sattler et al., 2002), and phagocytosis
(Gu et al., 2003). For Gab1 and Gab2, the SHP2–Gab interac-
tion is thought to regulate the ERK pathway, whereas the p85
binding sites are important for AKT activation.
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Retinoic acid (RA) plays a fundamental role in the devel-
opment of the central nervous system, stimulating neurite out-
growth and migration of the neural crest (Maden and Holder,
1992). During the differentiation process, several FGFs and
FGFRs are expressed. bFGF is highly expressed in the nervous
system and has multiple roles. It is a differentiation factor in the
hippocampus and has neurotrophic activities, supporting the sur-
vival and growth of cultured neurons and neural stem cells
(NSCs; Gage, 2000; Reuss and von Bohlen und Halbach, 2003).
NSCs are found in the hippocampus and subventricular zone
(SVZ) of fetal and adult brain and are more committed cells with
limited self-renewal capabilities and with the potential to differ-
entiate into neurons, astrocytes, and oligodendrocytes (Gage,
2000). P19 embryonic carcinoma (EC) cells are pluripotent stem
cells similar to embryonic stem (ES) cells. They are induced by
RA to differentiate into neuron- and glia-like cells (McBurney et
al., 1982). RA treatment also induces apoptosis in EC cells.
bFGF was reported to suppress RA-associated apoptosis, possi-
bly via the PI3K pathway (Miho et al., 1999). However, the
mechanism for bFGF-mediated activation of the PI3K pathway
in EC or ES cells and the interaction between bFGF and RA dur-
ing neuronal differentiation remain to be clarified.
We show that Gab2 expression markedly increases dur-
ing RA-induced differentiation of EC and ES cells along the
neural lineage. Gab2 expression is high in NSCs and persists in
neurons after differentiation. Further, Gab2, acting through the
PI3K–AKT pathway, plays a key role in bFGF-mediated cell
survival in EC cells, inhibiting the apoptosis that accompanies
RA-induced neural differentiation. Gab2 gene silencing by
small hairpin RNA (shRNA) vectors not only reduces the num-
ber of surviving cells after RA treatment but also diminishes
the percentage and quality of the neurons that emerge. Lastly,
lentiviral transduction of Gab2 shRNA into NSCs markedly in-
hibits the ability of bFGF to support neurosphere formation and
also impairs neuronal survival during differentiation. Together,
these results demonstrate for the first time that Gab2 may be an
important component of neural differentiation.
 
Results
 
Gab2 is part of the FGF signaling pathway
 
We examined the expression levels of mammalian Gab mem-
bers in P19 cells by semiquantitative RT-PCR (Fig. 1 A). All
three Gab proteins were present, with Gab3 being expressed at
the highest levels, whereas Gab1 levels were the lowest. We
initially focused on Gab2, which has been shown to function as
an adaptor protein downstream of numerous receptors but not
the FGFR. After stimulation with bFGF, Gab2 showed in-
creased tyrosine phosphorylation, accompanied by coimmuno-
precipitation with the p85 subunit of PI3K (Fig. 1 B). Gab2
contains a PH domain, which in Gab1 is known to bind to
phosphatidylinositol-3,4,5-P
 
3
 
 (PIP
 
3
 
) on the membrane (Maroun
et al., 1999). Cells were transiently transfected with HA-Gab2.
In starved cells, Gab2 was diffusely localized in the cytoplasm,
but in response to bFGF, a subpopulation of Gab2 was re-
cruited to the plasma membrane (Fig. 1 C). These results show
that Gab2 is a component of the bFGF pathway.
 
Gab2 is essential for bFGF-mediated cell 
survival during RA-induced cell death
 
P19 cells undergo neuronal differentiation in response to RA.
RA also induces apoptosis, which is rescued by exogenous
bFGF (Miho et al., 1999). To determine if bFGF acts through
Gab family proteins to counteract RA-induced cell death, we
constructed shRNA vectors to specifically silence Gab2 and
Gab3 expression in P19 cells. The 3
 
 
 
-UTRs of Gab2 and Gab3
were selected as targets to enable subsequent reconstitution
with Gab mutants. As the 3
 
 
 
-UTR sequence of Gab2 is not
available, we used 3
 
 
 
-RACE to amplify it from 32D mouse my-
eloid cells. Transient transfection assays demonstrated that the
Gab2 and Gab3 shRNA constructs were specific and efficient
as they suppressed 70–90% of the appropriate reporter activ-
ity (Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200505061/DC1).
We next examined the ability of the Gab2 and Gab3
shRNA vectors to suppress endogenous gene expression. Semi-
quantitative RT-PCR showed that Gab2 shRNA specifically si-
lenced endogenous Gab2 expression but did not affect Gab1 or
Gab3 expression in transient knockdown experiments (Fig. 2 A).
Similar specificity was demonstrated for the Gab3 shRNA.
Neither Gab2 nor Gab3 shRNA suppressed 
 
 
 
-actin levels. We
next determined if knockdown of Gab2 and Gab3 affected the
viability of P19 cells when treated with RA. Consistent with a
role for Gab2 in survival signaling, Gab2 silencing sensitized
P19 cells to RA-induced cell death (Fig. 2 B). Only 30% of the
Gab2 shRNA-transfected cells survived upon RA treatment,
compared with 75% of cells transfected with either control or
Gab3 shRNA. bFGF increased the survival of cells transfected
with control or Gab3 shRNA but not Gab2 shRNA. As trans-
fection with Gab3 shRNA did not increase cell death in re-
sponse to RA, Gab2 may play a unique role in mediating cell
Figure 1. Gab2 functions downstream of bFGF. (A) Expression levels of
Gab1, 2, and 3 in P19 cells were estimated by semi-quantitative RT-PCR.
 -Actin levels were used as a control. (B) Gab2 immunoprecipitates from
cells treated as indicated were analyzed sequentially by  -PY and  -Gab2
blotting. TCL, total cell lysate. (C) P19 cells were transfected with HA-
Gab2 and starved overnight as in B. FGF-stimulated (15 min) and unstimu-
lated cells were stained with  -HA antibody. Bars, 10  m. 
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survival. In support of this hypothesis, reconstitution of Gab2
shRNA-transfected cells with wild-type (WT) Gab2 reversed
the hypersensitivity to RA-induced cell death and restored the
ability of bFGF to promote survival. We confirmed that cell
death occurred via apoptosis by Annexin-V (Fig. 2 C) and
Hoechst (not depicted) staining. In agreement with Fig. 2 B,
there were more Annexin-V–positive cells and fragmented nu-
clei in Gab2 shRNA-transfected cells after RA treatment com-
pared with control shRNA-transfected cells. Because Gab2
knockdown had such a significant effect, we did not investigate
the role of Gab1, which is expressed at much lower levels.
In the presence of FBS alone, RA had a more modest ef-
fect on the viability of parental and control cells (Fig. 2 B, first
and third columns). We reasoned that bFGF may be present in
the conditioned medium because a previous study showed that
media conditioned by P19 cells contain multiple heparin-binding
growth factor activities (Heath et al., 1989). To test this possi-
bility, we used either a neutralizing antibody to bFGF (bFM-1)
or a specific kinase inhibitor of FGFR, PD173074 (Bansal et
al., 2003; Nilsson and Skinner, 2004). Neither significantly af-
fected the viability of parental P19 cells in the absence of RA,
but in the presence of RA, bFM-1 (Fig. 2 D) or PD173074 (not
depicted) could further reduce cell viability in a dose-depen-
dent manner. These results are consistent with the presence of
bFGF in the conditioned medium and with the ability of endog-
enous bFGF to protect against RA-induced cell death. FGF/
FGFR inhibition was deleterious only when RA was present,
suggesting that bFGF
 
 
 
s survival function is particularly impor-
tant during neuronal differentiation.
Stable Gab2 knockdown in P19 cells was achieved by
cotransfection with Gab2 shRNA and a vector containing the
puromycin resistance gene. Three puromycin-resistant clones
showed greatly reduced Gab2 expression compared with paren-
tal or control shRNA-transfected cell lines (Fig. 3 A). When
grown in complete medium, cells expressing Gab2 shRNA
showed modest growth reduction compared with control cells
(Fig. 3 B). In agreement with the transient transfection findings,
cells with stable Gab2 silencing also showed hypersensitivity to
RA-induced cell death and were not rescued by exogenous
bFGF (Fig. 3 C). Moreover, reconstitution of stable knockdown
cells with WT Gab2 reversed the hypersensitivity to RA-induced
cell death and restored the protective effect of bFGF. Similar to
Figure 2. bFGF-mediated cell survival is Gab2 dependent. (A) P19 cells
were transiently transfected with shRNA vectors. Expression levels of
Gab1, 2, and 3 were determined by semi-quantitative RT-PCR. (B) P19
cells, transfected with the indicated plasmids, were treated with RA  
bFGF for 48 h. Apoptotic and viable cells were counted using a hemocy-
tometer and Trypan blue staining, and viability was calculated as a per-
centage of surviving to total cells. Shown is the mean   SD (n   7 for all
conditions except for the untransfected cells [n   5]; **, P   0.0005).
(C) Cells were treated as in B and apoptotic cells were detected by FITC-
labeled Annexin-V staining. Total cell number and the number of Annexin-V–
positive cells were obtained from five different fields. Greater than 400
cells were counted for each condition. Shown is the mean   SD, based on
five fields. (D) P19 cells were preincubated with different concentrations of
bFM-1 for 1 h and treated as described in B. Shown is the mean   SD
(n   4; **, P   0.001).
Figure 3. Gab2 can be stably silenced by shRNA transfection. (A) Shown
are  -Gab2 immunoblots for parental P19 cells, a stable clone transfected
with control shRNA, and three stable clones transfected with Gab2
shRNA. (B) Stable clones described in A were seeded in  -MEM/10%
FBS. Cell numbers were counted for 4 d as described in Fig. 2 B. This is a
representative experiment out of three. (C) Parental P19 cells and their sta-
ble derivatives expressing Gab2 shRNA were transiently transfected with
vector or WT Gab2 and treated as described in Fig. 2 B. Apoptotic and
surviving cells were counted as described in Fig. 2 B. Shown is the per-
centage of surviving to total cells (mean   SD; n   4; **, P   0.001).
(D) Stable control and Gab2-silenced cells were preincubated with 20
 g/ml bFM-1 for 1 h and treated as described in Fig. 2 D. Shown is the
percentage of surviving to total cells (mean   SD; n   4; **, P   0.001). 
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the effect of bFGF/FGFR inhibition on parental cells (Fig. 2 D),
bFM-1 (Fig. 3 D) or PD173074 (not depicted) could further re-
duce the viability of control shRNA-transfected cells in the
presence of RA but without exogenous bFGF. Consistent with
Gab2 being a downstream target of bFGF/FGFR, ablation of
Gab2 expression eliminated any additional effect of bFGF/
FGFR inhibition on cell survival (Fig. 3 D). Together, these re-
sults indicate that bFGF, present in the conditioned medium, is a
key survival factor for P19 cells, protecting them from signifi-
cant cell death induced by RA, and that bFGF/FGFR works
through Gab2 to mediate survival. Because exogenous bFGF
conferred additional protection, the bFGF levels in the condi-
tioned medium were at submaximal levels.
 
Gab2 regulates bFGF-mediated cell 
survival mainly through the AKT pathway
 
To determine which bFGF-mediated signaling pathway uses
Gab2, we first demonstrated, using an 
 
 
 
-phosphorylated ERK
antibody and an in vitro AKT kinase assay, that both the ERK
and AKT pathways were activated upon bFGF stimulation
(Fig. 4 A). Next, we used the PI3K inhibitor LY294002 (LY)
and the MEK1 inhibitor U0126 to assess the importance of
PI3K and ERK in mediating cell survival. Dose-dependent ti-
tration of the inhibitors showed that 10 
 
 
 
M LY or U0126 was
sufficient to block bFGF-mediated AKT or ERK activation
(Fig. 4 B). Therefore, we used 10 
 
 
 
M of either inhibitor in an
MTS cell viability assay (Fig. 4 C). RA reduced cell viability
by 
 
 
 
40%, and viability was fully restored by bFGF. When
used alone, LY or U0126 reduced survival by 40 and 25%, re-
spectively. Addition of RA, in combination with either LY or
U0126, further decreased cell viability to 40 and 50% of un-
treated cells, respectively. bFGF had a marginal protective effect
when both pathways were inhibited simultaneously but this
was not statistically significant. These findings indicate that the
PI3K and ERK pathways are required for bFGF-mediated cell
survival during RA-induced cell death.
Because PI3K and ERK activities were important for P19
survival, and Gab2 silencing markedly reduced bFGF-dependent
survival, we tested if Gab2 can function downstream of bFGF
to mediate PI3K–AKT and ERK activation. Control, Gab2, or
Gab3 shRNA was transiently cotransfected with FLAG-AKT
into P19 cells. Compared with control or Gab3 shRNA-trans-
fected cells, bFGF-induced AKT activity was reduced by
 
 
 
80% in Gab2-silenced cells (Fig. 5 A). We further validated
that the reduction in AKT activity was specifically due to Gab2
silencing by cotransfection with Gab2 shRNA and WT Gab2
(Fig. 5 B). Maximal AKT activation requires phosphorylation
at both T308 and S473. In addition to a reduction in AKT T308
phosphorylation, AKT phosphorylation at S473 was almost
abolished, implying that Gab2 is essential for S473 phosphory-
lation. WT Gab2 reconstitution in Gab2-silenced cells greatly
enhanced AKT phosphorylation on both T308 and S473 (Fig.
5 B). These results confirm a specific effect of Gab2 silencing
on bFGF-induced Akt activation.
Next, we determined if Gab2 suppression affected bFGF-
mediated ERK activation. Myc- or HA-tagged ERK was
cotransfected with the indicated shRNA constructs (Fig. 5, C
and D). In contrast to AKT, bFGF-induced ERK activation was
not affected by Gab2 silencing. Moreover, reconstitution with
WT Gab2 did not increase ERK activation, suggesting that
bFGF-provoked ERK activation is Gab2 independent. To-
gether, our results imply that Gab2-dependent bFGF-mediated
cell survival occurs via the PI3K–AKT pathway. Consistently,
constitutively active AKT (E40K) and to a much lesser extent
constitutively active MEK (R4F) rescued RA-induced cell
death in Gab2-silenced cells (Fig. 5 E).
Previous studies showed that RA activates the p38 and JNK
pathways (Alsayed et al., 2001; Wang et al., 2001). We tested
the possibility that bFGF may regulate RA-induced cell death
through p38 and JNK. Our results demonstrated that although
bFGF or RA could transiently activate JNK and p38 in P19 cells,
inhibitor studies showed that these kinases were not important
components of the bFGF survival pathway (Fig. S2, available at
http://www.jcb.org/cgi/content/full/jcb.200505061/DC1).
 
The PH domain of Gab2 is required for 
its function
 
Gab2 undergoes growth factor–dependent phosphorylation at
multiple tyrosines including those that dock p85/PI3K. We de-
termined how a Gab2 mutant lacking p85 binding sites (3YF)
responded to bFGF stimulation. Parental P19 cells were tran-
siently cotransfected with WT or 3YF along with FLAG-AKT.
The 3YF mutant showed decreased bFGF-induced tyrosine
phosphorylation compared with WT. Moreover, AKT activa-
tion in 3YF-overexpressing cells was reduced compared with
Figure 4. AKT and ERK pathways modulate bFGF-mediated survival.
(A) 40  g of total cell lysates were probed with  -pERK and reprobed
with  -total ERK antibodies (top). An in vitro AKT kinase assay was per-
formed to measure AKT activity (bottom). The top part of the membrane
was probed with  -pAKT, stripped, and reprobed with  -total AKT anti-
bodies. The bottom part of the membrane was probed with  -pGSK3 anti-
body to detect phosphorylation of the substrate in the kinase assay, a
GSK3 fusion protein. (B) Starved P19 cells were pretreated with different
concentrations of LY or U0126 for 1 h and stimulated with 10 ng/ml bFGF
for 15 min. AKT and ERK activation was detected with  -pAKT and  -pERK
antibodies, respectively. (C) P19 cells were treated as shown. MTS absor-
bance (A490) units are plotted as a percentage of that measured in untreated
cells and shown as the mean   SD (n   4; *, P   0.05; **, P   0.005). 
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vector control, indicating that the 3YF mutant exerts a domi-
nant-negative effect over endogenous Gab2 (Fig. 6 A).
The PH domain of Gab2 is important for recruitment to
the phagocytic cup (Gu et al., 2003). To examine the role of the
PH domain in bFGF signaling, we transiently overexpressed
Gab2 mutants, either 
 
 
 
PH (which lacks the PH domain) or
 
 
 
PH/3YF (a combination of 3YF and 
 
 
 
PH mutations). 
 
 
 
PH
and 
 
 
 
PH/3YF mutants showed markedly reduced bFGF-induced
tyrosine phosphorylation (Fig. 6 B). AKT activation was also
greatly reduced in cells expressing either mutant, compared
with cells expressing WT Gab2, but was similar to vector-
transfected cells. These results indicate that the PH domain of
Gab2 is required for optimal bFGF-induced tyrosine phosphor-
ylation and provide an explanation for the dominant-negative
effect of 3YF. Consistent with their degree of AKT activation,
3YF, 
 
 
 
PH, and 
 
 
 
PH/3YF were unable to reverse the hypersen-
sitivity to RA-induced cell death caused by Gab2 silencing
(Fig. 6 C).
 
RA-induced neuronal differentiation 
is accompanied by marked Gab2 
up-regulation
 
The P19 cell line is a good in vitro model to study RA-induced
neuronal differentiation (McBurney et al., 1982). Given that
bFGF has a critical role in protecting P19 cells against RA-
associated cell death, we determined the effect of depleting
endogenous bFGF during differentiation. We used neuron-
specific 
 
 
 
-III tubulin as a marker for neuronal differentiation.
By immunofluorescence, only 50% as many cells survived af-
ter differentiation in the presence of bFM-1 compared with its
absence (Fig. 7 A, left), and, of these, only 
 
 
 
40% were neu-
rons, compared with 
 
 
 
90% in cultures where bFGF was not
depleted (Fig. 7 A, right). Next, we investigated if Gab2 ex-
pression was altered during neuronal differentiation. Gab2 lev-
els increased dramatically when P19 cells differentiated into
neuron-like cells (Fig. 7 B). 
 
 
 
-III tubulin expression showed
kinetics similar to Gab2 expression. We then determined if
bFGF affected the kinetics of Gab2 expression during differen-
tiation. The presence of bFGF hastened the appearance of Gab2
as well as 
 
 
 
-III tubulin (Fig. 7 B). Thus, depleting bFGF levels
in the conditioned medium decreased the total number of sur-
viving cells as well as the percentage of neurons (Fig. 7 A),
whereas increasing the levels of bFGF by exogenous addition
had the opposite effect (Fig. 7 B). These findings suggest that
bFGF in combination with RA facilitated an earlier commit-
ment of P19 cells to the neural fate. The increase in Gab2 levels
could be a specific response to RA treatment or intrinsic to the
neuronal differentiation program in P19 cells.
Figure 5. Gab2 mediates survival through the AKT pathway.
(A) P19 cells were transiently transfected with plasmids as in-
dicated and stimulated with bFGF. FLAG-tagged AKT was
precipitated and an in vitro AKT kinase assay was performed
as described in Fig. 4 A. Gab2 levels were measured to
demonstrate efficient knockdown of Gab2. (B) P19 cells were
transiently transfected with the indicated plasmids and stim-
ulated by bFGF. FLAG-AKT precipitates were probed se-
quentially with  -pAKT (T308),  -pAKT (S473), and  -FLAG
antibodies. (C and D) P19 cells were transiently transfected
with Myc- or HA-ERK and the indicated shRNA plasmids,
and then bFGF stimulated. Total cell lysates were probed
with  -Myc (C) or  -HA (D) antibody to detect phosphoryla-
tion-induced mobility shift of ERK. (E) P19 cells were trans-
fected with various combinations of plasmids and treated as
described in Fig. 2 B. Shown is the percentage of living to
total cells (mean   SD; n   3; **, P   0.005). 
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We then asked if silencing of Gab2 affected RA-induced
neuronal differentiation in P19 cells. Stable clones expressing
either control or Gab2 shRNA were induced by RA to differenti-
ate. Both Gab2 and 
 
 
 
-III tubulin expression increased in fully
differentiated cells expressing control shRNA (Fig. 7 C). Simi-
lar to the effect of bFM-1, cells where Gab2 was stably silenced
showed significantly reduced expression of 
 
 
 
-III tubulin, indi-
cating that Gab2, like bFGF, plays a role in neuronal differenti-
ation. Because RA induces P19 to differentiate into both neu-
ron- and glia-like cells, we tested the expression pattern of
Gab2. After differentiation, cells expressing control or Gab2
shRNA were doubly stained with antibodies to Gab2 and 
 
 
 
-III
tubulin (Fig. 7 D). Gab2 was present in 
 
 
 
-III tubulin–positive
cells. Consistent with a role for Gab2 in protecting cells against
RA-induced cell death, when Gab2 was stably silenced, fewer
cells survived differentiation, compared with cells expressing
control shRNA (Fig. 7 E, left). Moreover, fewer 
 
 
 
-III tubulin–
positive cells emerged from the Gab2-silenced clone after RA
treatment (Fig. 7 E, middle) and these cells were abnormal in
appearance, showing greatly shortened neurite extensions (Fig.
7 D; and Fig. 7 E, right). These data demonstrate that in P19
cells, Gab2, like bFGF, is important for neuronal differentiation.
To further confirm a function for Gab2 in embryonic neu-
ronal differentiation, ES cells were induced to differentiate into
neurons using the 4
 
 
 
/4
 
 
 
 RA protocol (Bain et al., 1995).
First, we verified that the FGF signaling pathway was similarly
important in ES cells. We determined the number of ES cells
that survived differentiation in the presence or absence of
PD173074. For both P19 and ES cells (Fig. 8 A), 50 nM
PD173074 was sufficient to reduce the number of surviving
cells by 50%. Next, we examined Gab2 expression in ES cells.
Gab2 was low in proliferating ES cells, but expression in-
creased significantly upon RA induction (Fig. 8, B and C), sim-
ilar to that described for P19 cells (Fig. 7 B). Immunofluores-
cence further showed that most cells stained positive for Gab2
and 
 
 
 
-III tubulin. A few were Gab2 positive and  -III tubulin
negative, whereas others were negative for both (Fig. 8 D). To-
gether, these results demonstrate that Gab2 and bFGF exert
similar effects during RA-induced neuronal differentiation in
P19 cells and ES cells and that Gab2 is likely to be functioning
as a bFGF effector.
The role of Gab2 in NSCs
So far, we have shown that Gab2 is required for bFGF-medi-
ated cell survival and that Gab2 expression is increased during
RA-induced embryonic neuronal differentiation, which is fur-
ther enhanced by the addition of bFGF. To study the role of
Gab2 in stem cells committed to a neural fate, NSCs were iso-
lated from the SVZ of postnatal mice and cultured as floating
neurospheres. Neurospheres are dependent on either bFGF or
EGF for growth (Reynolds and Weiss, 1992), and upon re-
moval of growth factors they can be induced to differentiate
into neurons, astrocytes, and oligodendrocytes. Addition of RA
is reported to increase the number of cells differentiating into
neurons (Takahashi et al., 1999). Primary neurospheres were
dissociated and plated in medium containing 1% FBS alone or
with RA or RA and 10 ng/ml bFGF and allowed to differentiate
for 7 d. Removal of bFGF greatly increased the death of NSCs
(Fig. 9 A, left). Addition of RA to NSCs further reduced cell
survival. After 7 d of differentiation, 42% of surviving cells in
the presence of RA were neurons, compared with 35% in its
absence, although this difference was not statistically signifi-
cant (Fig. 9 A, right). Previous observations had shown that the
maximal enhancing effect of RA is apparent only at  12 d af-
ter RA removal (Takahashi et al., 1999). Cell viability was
markedly increased when bFGF was added along with RA.
However, the percentage of neurons was less, with a concomi-
tant increase in glia identified by glial fibrillary acidic protein
(GFAP) staining (Fig. 9 B). This is consistent with a previous
report that high concentrations (10 ng/ml) of bFGF promote
glial generation (Qian et al., 1997).
We next examined the role of Gab2 in NSCs. Undifferen-
tiated neurospheres stained strongly for Gab2 (Fig. 9 B, top),
Figure 6. bFGF-induced optimal AKT activation requires Gab2. (A) P19
cells were transiently cotransfected with the indicated Gab2 constructs
and FLAG-AKT, and then stimulated by bFGF. HA-Gab2 precipitates were
sequentially blotted with  -PY and  -HA antibodies. FLAG-AKT precipi-
tates were probed sequentially with  -pAKT and  -FLAG antibodies. (B)
P19 cells were transiently transfected and stimulated as described in A.
HA-Gab2 precipitates were probed sequentially with  -PY and  -HA anti-
bodies. FLAG-AKT precipitates were used in an in vitro AKT kinase assay
as described for Fig. 4 A. (C) Gab2 shRNA was cotransfected with vector
or various Gab2 constructs into P19 cells. Cells were treated as described
in Fig. 2 B. Shown is the percentage of surviving to total cells (mean  
SD; n   3; **, P   0.005). (bottom) A Gab2 blot of total cell lysates.
White lines indicate that intervening lanes have been spliced out.GAB2 AND BFGF IN NEURONAL DIFFERENTIATION • MAO AND LEE 311
indicating that Gab2 expression is already elevated in NSCs.
Because neurospheres in culture are considered to be heteroge-
neous (Pevny and Rao, 2003), we cannot exclude the possibil-
ity that there are already more committed progenitors in our
cultures, although Gab2 staining appeared to be relatively ho-
mogeneous. When induced to differentiate, Gab2 was again
detected in neurons (Fig. 9 B). Several small, phase-dark cells
also stained positive for Gab2, but Gab2 was barely detectable
in GFAP-positive astrocytes. To test if Gab2 is required for
bFGF-mediated proliferation, neurospheres were transduced by
a lentivirus expressing control or Gab2 shRNA with GFP as a
marker. Gab2 expression was greatly reduced by Gab2 shRNA,
compared with cells transduced by a control shRNA lentivirus
or to untransduced cells (Fig. 9 C). A clonal assay was con-
ducted to determine how Gab2 silencing affected neurosphere
proliferation. Transduced neurospheres were grown in the pres-
ence of bFGF alone for 8 d. Silencing of Gab2 in NSCs mark-
edly diminished their ability to generate neurospheres, and the
size of neurospheres was significantly smaller compared with
those transduced with a control shRNA (Fig. 9 D). Thus, Gab2
is required for bFGF-mediated proliferation of NSCs.
To determine if Gab2 is required for neuronal survival
during NSC differentiation, transduced neurospheres were dif-
ferentiated in the presence of 1% FBS and neuronal apopto-
sis was measured using an antibody that recognizes cleaved
caspase-3. 72 h after differentiation induction, 32% of GFP-
positive neurons were apoptotic in Gab2-silenced cells com-
pared with 8% in cells transduced with a control shRNA (Fig.
9 E). Consistently, Gab2 suppression reduced the number of
surviving, GFP-positive neurons by 60–70% (Fig. 9 E), which
is to be contrasted to a difference of only 27% in the GFP-posi-
tive, nonneuronal population. This latter difference is in agree-
ment with minimal Gab2 expression in astrocytes (Fig. 9 B)
and may reflect the difference in transduction efficiencies (con-
trol, 60%; Gab2 shRNA, 50% at the time of plating). Together,
our data implicate Gab2 as being essential for optimal neuronal
generation, in part by providing survival signals during neu-
ronal differentiation. Based on the present findings, we cannot
exclude an additional role for Gab2 in specifying the neuronal
fate during commitment.
Discussion
Gab1, Gab2, and Gab3 null mice have profoundly different phe-
notypes ranging from embryonic lethality (Gab1) to apparent
normalcy (Gab3; Itoh et al., 2000; Gu et al., 2001; Seiffert et al.,
2003), consistent with the Gab proteins having distinct func-
tional roles in development. In this work, we used RNA inter-
ference to silence Gab2 and Gab3 in the P19 EC cell line and
showed that these proteins have nonoverlapping functions in
Figure 7. Gab2 regulates RA-induced neuronal differentiation
in P19 cells. (A) P19 cells were induced to differentiate by RA
with or without 20 ng/ml bFM-1. Cells surviving at the end of
the differentiation protocol were stained with  - -III tubulin to
visualize neurons and with Hoechst dye to visualize all cells.
Total cell number and the number of  -III tubulin–positive cells
were obtained from 10 different fields. Greater than 500
cells were counted for each experiment. (left) Surviving cells
are shown as a percentage of that in the absence of bFM-1.
(right)  -III tubulin–positive cells are expressed as a percent-
age of total surviving cells. Results are plotted as the mean  
SD (n   4; *, P   0.05). (B) P19 cells were treated with RA
in the absence (top) or presence (bottom) of bFGF for the in-
dicated times. Cells were harvested and blotted for Gab2
and  -III tubulin expression. Fold induction was calculated by
normalizing Gab2 to actin levels. (C) Stable clones trans-
fected with control or Gab2 shRNA-2 were induced to differ-
entiate by RA. Undifferentiated cells were harvested at the
beginning of the experiment and differentiated cells 9 d later.
(D) 9 d after initiation of RA treatment, stable clones express-
ing control or Gab2 shRNA were doubly stained with anti–
 -III tubulin (Cy3) and rabbit  -Gab2 (AF 488). Nuclei were
visualized by Hoechst staining (blue). Gab2 was primarily in
cells that were  -III tubulin positive. A few cells were Gab2
and  -III tubulin negative (arrows). Bars, 50  m. (E) The num-
ber of surviving cells (left) and neurons (middle) were esti-
mated as described in A 9 d after RA induction. The lengths
of neurites were measured using a micrometer scale bar
(right). 50  -III tubulin–positive cells were measured for each
experiment. Shown is the mean   SD (n   4; *, P   0.05).JCB • VOLUME 170 • NUMBER 2 • 2005 312
bFGF survival signaling. Gab2, but not Gab3 suppression, re-
duced bFGF-mediated AKT activity and abrogated bFGF’s
ability to protect P19 cells from RA-induced cell death. In addi-
tion, Gab2 relayed the bFGF signal to AKT and not ERK, and it
required both its PH domain and p85/PI3K binding sites to sig-
nal downstream. These results support the conclusion that Gab2
is a critical positive regulator of bFGF-stimulated signaling and
that it modulates bFGF signaling mainly through the AKT path-
way. Using the EC and ES system, we also demonstrated for the
first time that Gab2 expression increased dramatically during
embryonic neural differentiation, and in EC cells, Gab2 silenc-
ing significantly affected this process. Gab2 was already highly
expressed in NSCs, suggesting that up-regulation of Gab2 may
occur at the neural commitment stage, before neuronal differen-
tiation. Lastly, Gab2 silencing in NSCs markedly reduced the
ability of bFGF to support neurosphere proliferation and inhib-
ited neuronal survival when NSCs were induced to differenti-
ate. As Gab2 has been reported to participate in mast cell and
macrophage differentiation (Gu and Neel, 2003), it may have a
more general role in cellular differentiation.
During development, various extracellular signaling mole-
cules modulate neuronal differentiation. RA is one such
molecule. RA is teratogenic when administrated in excess to
pregnant animals and affects multiple systems including the
central nervous system (Maden and Holder, 1992). In Xenopus
laevis, RA regulates pattern formation of the vertebrate neural
plate, by up-regulating prepattern and neurogenic genes, and
by down-regulating genes that inhibit neurogenesis (Franco et
al., 1999). FGFs are also important factors of neuronal differen-
tiation. bFGF participates in the development of the cerebral
cortex and supports the proliferation of NSCs from the SVZ
(Reynolds and Weiss, 1992; Dono et al., 1998). The FGF and
RA pathways have been shown to have opposing effects in vivo
(Appel and Eisen, 2003). During spinal cord development in the
chick embryo, FGF blocks expression of class I HD/bHLH tran-
scription factors and Sonic hedgehog. This inhibits neurogene-
sis and maintains the caudal region as a stem zone. On the other
hand, RA, arising from somites, antagonizes the FGF signal and
promotes neurogenesis by up-regulating class I genes. Thus,
FGF and RA coordinate the initiation of neurogenesis.
Gab2 is expressed in the brain but little is known about its
function there. Our results firmly establish that Gab2 has a role
in neural function and provides a link between bFGF and RA in
embryonic neural differentiation. bFGF plays a complex role
during neural development. It supports the proliferation and
survival of ES cells and is needed for the expansion and mainte-
nance of neuroectodermal and neural precursor cells (Reynolds
and Weiss, 1992). When neural precursor cells are induced to
differentiate, the ratio of neurons to other cell types in culture
appears to depend on the levels of bFGF present, low doses
(0.1 ng/ml) favoring neuronal differentiation and high doses
(10 ng/ml) glial generation (Qian et al., 1997). In EC cells,
Gab2 expression is markedly increased during RA-induced
neural differentiation and is further enhanced by the addition of
bFGF. Depletion of endogenous bFGF gives rise to a pheno-
type which is similar to that induced by Gab2 silencing. This
leads to the interesting possibility that Gab2 may play a role in
bFGF-dependent maintenance/expansion of neural precursors.
Consistently, NSCs that are already committed to the neural
fate but still retain the potential to differentiate, show high lev-
els of Gab2 expression and Gab2 silencing significantly reduced
NSC proliferation. bFGF may further modulate neurogenesis
Figure 8. Gab2 is highly expressed during ES neuronal
differentiation. (A) P19 and ES cells were induced by RA to
undergo differentiation in the presence or absence of 50 nM
PD173074. At the end of the differentiation protocol, cell vi-
ability was measured as described in Fig. 7 A (n   2). D3 (B)
and J1 (C) ES cells at the indicated times during the 4 /4 
RA differentiation protocol were harvested and analyzed for
Gab2 and  -III tubulin expression. (D) D3 cells were induced
to differentiate as described in B. 12 d after initiating differ-
entiation, cells were multiply stained with  - -III tubulin (Cy3),
purified rabbit  -Gab2 (AF 488), and Hoechst dye (blue).
Arrows point to cells that are doubly negative for Gab2 and
 -III tubulin. Other cells stained for Gab2 only (arrowheads).
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when NSCs are induced to differentiate. In the presence of ex-
ogenous bFGF, more cells survive but there is a concomitant
reduction in the ratio of neurons to other cells, consistent with
previous observations that high dose bFGF promotes glial for-
mation. In the absence of exogenous bFGF, low levels of bFGF
may still be present in the conditioned medium because neu-
rons and astrocytes are reported to secrete bFGF (Reuss and
von Bohlen und Halbach, 2003). Thus, the effect on differenti-
ation due to Gab2 suppression could still reflect a bFGF effect.
However, neurotrophins are also secreted by NSCs and their
receptors are up-regulated during differentiation (Barnabe-
Heider and Miller, 2003). Therefore we cannot exclude the
possibility that Gab2 also functions downstream of Trk recep-
tors to modulate the fate specification of multipotential progen-
itors. Irrespective of which upstream signal Gab2 is responding
to during NSC differentiation, our data clearly support an es-
sential role for Gab2 in mediating neuronal survival. Interest-
ingly, because Gab2 expression was prominent in neurons but
not astrocytes after NSC differentiation, our findings also argue
for a possible role of Gab2 in lineage selection.
A key finding of our studies is that Gab2 regulates the
bFGF survival pathway mainly through AKT. Both the p85
binding sites and the PH domain of Gab2 are crucial for bFGF-
stimulated AKT activation. Suppression of Gab2 does not com-
Figure 9. Gab2 knockdown impairs bFGF-mediated NSC proliferation and neuronal differentiation. (A) Primary NSCs differentiated for 7 d in the
presence of 1% FBS alone or with 1  M RA   10 ng/ml bFGF. Total cell number and the number of  -III tubulin–positive cells were obtained from 10
different fields. (left) Greater than 1,000 cells were counted for each experiment. Cell viability is shown as a percentage of number of surviving to input
cells (means   SD; n   3; *, P   0.05; **, P   0.005). (right) 400–800  -III tubulin–positive cells were counted and plotted as a percentage of total cell
number (mean   SD; n   3; **, P   0.005). (B) NSCs were differentiated as described in A. Cells were multiply stained with rabbit  -Gab2 (AF 488),
 - -III tubulin (Cy3), and Hoechst dye (blue). Several cells stained for Gab2 only (arrows). Separate samples were also stained with  -GFAP (AF 488).
(C) Neurospheres were transduced by control or Gab2 shRNA lentivirus and after 48 h stained with  -Gab2 and Hoechst. Transduced cells are identified
by GFP expression (arrows). Arrowheads point to nontransduced cells. (D) Primary NSCs were transduced by control or Gab2 shRNA lentivirus, dissoci-
ated, and plated into uncoated 96-well plates under limiting dilution conditions (10 cell/well) in the presence of 20 ng/ml bFGF for 8 d. GFP-positive neu-
rospheres were scored by size (n   400). (E) NSCs were transduced and plated in the presence of 1% FBS. At 72 h after plating, GFP-positive cells that
also stained positive for  -III tubulin (AF 350) and active caspase 3 (Cy3) were obtained from 60 fields. Greater than 100 apoptotic neurons were ob-
tained for Gab2-silenced cells. The percentage of apoptotic neurons was determined by counting all GFP,  -III tubulin–positive cells from the same fields.
Arrows point to apoptotic, GFP-positive neurons. The number of viable, GFP-positive neurons was estimated in a similar experiment. Cells that were doubly
positive for GFP and  -III tubulin were obtained from 50 random fields and a minimum of 200 cells were obtained for NSCs transduced with either control
or Gab2 shRNA virus. Non-neuronal, GFP-positive cells were also obtained from the same fields and  2,000 cells were counted. (left) Shown are the
results from a representative experiment out of at least three independent experiments. Plotted are the actual cell numbers. Percent refers to the percent
reduction in Gab2-silenced cells compared to control cells.JCB • VOLUME 170 • NUMBER 2 • 2005 314
pletely eliminate AKT activation, indicating that Gab2-inde-
pendent pathways also exist. Gab3 is not a major contributor
because Gab3 silencing does not affect bFGF-induced AKT ac-
tivation. Deletion of the PH domain significantly reduces
bFGF-mediated Gab2 tyrosine phosphorylation and AKT acti-
vation, suggesting that Gab2 needs to be recruited to the
plasma membrane via PIP3 before it can become tyrosine phos-
phorylated. Altogether, these results support a model in which
bFGF stimulates a Gab2-independent pathway to induce early
PI3K–AKT activation. PIP3 generated during this early phase
then binds to the PH domain of Gab2, recruiting Gab2 to the
plasma membrane, whereby it becomes tyrosine phosphory-
lated at sites including those that dock p85. In this fashion, an
amplification loop is created resulting in further AKT activa-
tion. This model is consistent with the finding that 3YF-Gab2
when overexpressed, functions in dominant-negative fashion,
possibly by sequestering PIP3 and blocking signaling to AKT.
As we did not observe any defect in bFGF-mediated ERK
activation in Gab2-silenced P19 cells, FGFR probably uses
other proteins such as FRS2 to activate the ERK pathway. This
is supported by the report that FRS2 is required for FGF1-
induced ERK activation. Moreover, similar to our observations
on Gab2, Gab1 is essential for FGF1-induced PI3K–AKT, but
not ERK, activation (Lamothe et al., 2004). Although Gab2
does not appear to play a major role in bFGF-induced ERK ac-
tivation, it clearly contributes to ERK activation in response to
other stimuli. For example, while IgE-provoked ERK activa-
tion in Gab2 knockout mice is not affected (Gu et al., 2001),
Erk activation induced by BCR/ABL is clearly decreased
(Sattler et al., 2002). Thus, depending on the stimulus, Gab2
may have differential effects on ERK activation.
Until now, Gab2 was mainly considered to be a regulator
of hematopoiesis. Data shown in this study provide the first
demonstration that Gab2 also functions in the nervous system
by acting as a critical link between bFGF and the PI3K–AKT
pathway. No gross brain defect was reported in Gab2 null
mice; however, bFGF /  mice were also initially reported to
have normal brain morphogenesis. It was only recently that
these mice were found to have a significant decrease in the
number of neurons in the cerebral cortex (Dono et al., 1998). It
will be interesting to see if an in-depth investigation of Gab2
knockout mice will reveal defects in neural development and
neurological function.
Materials and methods
Reagents and antibodies
bFGF and EGF were obtained from PeproTech. All-trans RA and heparin
were obtained from Sigma-Aldrich. Cell culture reagents were purchased
from Invitrogen. The inhibitors used were as follows: U0126 (Cell Signaling);
LY (LC Laboratories); SP600125 and SB203580 (Calbiochem); PD173074
(a gift of K. Kilgore, Pfizer Global Research and Development, Ann Arbor,
MI). The antibodies used were as follows: JNK, AKT, myc (9E10), and actin
antibodies (Santa Cruz Biotechnology, Inc.); PY (4G10), and bFM-1 (UBI);
pAKT, pGSK3, pERK, active caspase-3 antibodies, and  -p-p38 antibody-
conjugated beads (Cell Signaling); FLAG (M2) and GFAP antibodies
(Sigma-Aldrich); HA and  -III tubulin antibodies (BABCO/Covance). Rabbit
 -Gab2 was purchased from UBI and goat  -Gab2 from Santa Cruz Bio-
technology, Inc. Cy3-conjugated secondary antibodies were from obtained
from Jackson ImmunoResearch Laboratories and AlexaFluor (AF)-conjugated
secondary antibodies were obtained from Molecular Probes.
Cell culture, DNA constructs, and transfection
P19 cells were cultured in  MEM/10% FBS. The D3 and J1 ES cells (gifts
of S. O’Shea, University of Michigan, Ann Arbor, MI) were cultured in
DME/10% FBS and 10
3 U/ml LIF (Chemicon) on 0.1% gelatin-coated tis-
sue culture dishes. WT and 3YF (Y441F, Y465F, Y574F) Gab2 (gifts of H.
Gu, Harvard University, Boston, MA) have been previously described (Gu
et al., 2001). A  PH mutant was generated by deletion of residues
6–115. A Myc- or HA-tagged ERK and FLAG-tagged WT AKT plasmid has
been described previously (Lee and States, 2000). The shRNA pU6 vector
and the control vector, pU6-XASH targeting an irrelevant frog protein,
were provided by D. Turner (University of Michigan, Ann Arbor, MI; J.Y.
Yu et al., 2002). We designed shRNA constructs to target against the 3 -
UTR of Gab2 and Gab3. The Gab2 and Gab3 target sequences are as
follows: Gab2 shRNA-1 (5 -GTTCAAGAGCCATGAGGCAGCTGCCC-3 ),
Gab2 shRNA-2 (5 -CCTATGACTTCTGTCAATAC-3 ), Gab2 shRNA-3
(5 -CAACATCAGGGACCTGACCCTTTCCCAT-3 ), Gab3 shRNA-1 (5 -
AAGTGTGGGCTTGGGTGTGATT-3 ), and Gab3 shRNA-2 (5 -CTTCCTC-
TTCTCTTTGTCCTCAGCAC-3 ). Based on results in Fig. S1, Gab2 shRNA-2
and Gab3 shRNA-2 were selected for subsequent transfection. To estab-
lish stable P19 Gab2 knockdown cell lines, the Gab2 shRNA-2 was
cotransfected with pPUR (CLONTECH Laboratories, Inc.) into P19 cells
and cells were selected in medium containing 1  g/ml puromycin. For
transient transfection, 0.8  g of the shRNA construct was cotransfected
with 0.2  g of a reporter plasmid (Myc-, HA-ERK, or FLAG-AKT) into P19
cells. Transfected cells were allowed to express for 24 h before starvation
and stimulation.
In vitro neuronal differentiation
Differentiation of P19 cells was induced as described previously (McBur-
ney et al., 1982). ES cells were differentiated using the 4 /4  RA proto-
col (Bain et al., 1995). In experiments to inhibit endogenous bFGF effects,
20  g/ml bFM-1 or 50 nM PD173074 was added at the beginning of the
differentiation process.
Isolation and culture of NSCs
NSCs from the SVZ of CD1 mice (Charles River Laboratories) at postnatal
day 14 were isolated and cultured as described previously (Gabay et al.,
2003). NSCs were grown as floating neurospheres in DME/F12 medium
containing N2 and B27 supplements plus 20 ng/ml bFGF, 5  g/ml he-
parin, and 20 ng/ml EGF for 7 d before being used for differentiation
experiments. To induce differentiation, neurospheres were dissociated
by trituration and 5–7.5   10
4 cells were plated onto coated glass cover-
slips or 24-well plates in DME/F12/1% FBS. In some wells, 1  M RA  
10 ng/ml bFGF was added.
Lentiviral transduction
Control XASH shRNA or Gab2 shRNA was ligated into pLentiLoX (a gift of
L. van Parijs, Massachusetts Institute of Technology, Boston, MA; Rubinson
et al., 2003). 293T cells were cotransfected with pMDLg/pRRE, pCMV-
VSVG, pRSV-REV, and either pLentiLoX-XASH or pLentiLoX-Gab2 shRNA
by calcium phosphate precipitation. VSVG-pseudotyped lentiviruses were
collected 48 after transfection and concentrated by ultracentrifugation at
36,000 rpm for 90 min. The viral titer was determined to be 2–10   10
8
TU/ml following an established protocol (Rubinson et al., 2003). To as-
sess the effect of Gab2 silencing in NSCs, neurospheres were first dissoci-
ated into single cells and allowed to recover in medium containing growth
factors for 8 h. Lentiviruses were then added for 12 h at a multiplicity of in-
fection of 20. Neurospheres were further allowed to recover for 36 h be-
fore plating for clonal expansion (Fig. 9 D) or differentiation (Fig. 9 E) as
described in the figure legends.
Stimulation, immunoprecipitation, and immunoblotting
Cells were starved in  MEM for 24 h and in all experiments stimulated
with both bFGF (100 ng/ml) and heparin (5  g/ml) for the times indi-
cated in the figure legends. Lysis, immunoprecipitation, and blotting were
performed as described previously (Lee and States, 2000). Protein con-
centration was determined with the assay kit (Bio-Rad Laboratories).
AKT kinase assay
Starved cells were stimulated with bFGF and lysed. 500  g of lysates
was precipitated with 1  g of  -AKT–conjugated protein G–Sepharose
and used in an in vitro kinase assay according to the manufacturer s pro-
tocol (Cell Signaling). After SDS-PAGE and transfer to PVDF, the bottom
part of the membrane was probed with  -p-GSK3 antibody, whereas the
top part containing AKT was probed sequentially with  -p-AKT and  -total
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Cell death assays
P19 cells were seeded in 12-well plates and transfected with various con-
structs. 24 h later, the transfected cells were treated with 1  M RA   10
ng/ml bFGF for 48 h. Dead cells were identified by Trypan blue exclusion
and by Hoechst 33258 (Sigma-Aldrich) staining. To block endogenous
bFGF, bFM-1 or PD173074 was preincubated with P19 cells for 1 h be-
fore RA treatment. FITC-labeled Annexin-V (BD Bioscience) staining of live
cells was used to confirm the presence of apoptosis. To measure prolifera-
tion/viability, P19 cells were starved for 16 h and treated with inhibitors
for 1 h before the addition of RA   bFGF. The number of surviving cells
was estimated 48 h later by the MTS assay (CellTiter 96 AQueous Non-
Radioactive Cell Proliferation Assay; Promega). To measure apoptosis in
neurons, differentiated NSCs were stained with antibodies to active
caspase-3 and  -III tubulin.
Immunostaining
To examine Gab2 translocation, P19 cells were plated on glass coverslips
and transfected with HA-Gab2. Cells were starved for 16 h in  MEM be-
fore stimulation with bFGF for 15 min. Immunostaining was performed es-
sentially as described previously (Gu et al., 2003). For double staining,
cells were seeded onto glass coverslips coated with poly-D-lysine and fi-
bronectin or laminin. We immunopurified rabbit  -Gab2 by incubating
the IgG fraction with 2   1 cm nitrocellulose chips on which overex-
pressed Gab2 was immobilized. We performed double staining by add-
ing antibodies sequentially. The following dilutions were used: purified
rabbit  -Gab2 (1:260), HA (1:800), TuJ1 (1:4,000), GFAP (1:500), ac-
tive caspase-3 (1:100), AF 488 goat  -rabbit (1:150), AF 350 goat
 -mouse (1:100), Cy3-goat  -mouse (1:4,000), and Cy3-goat  -rabbit
(1:500). Epifluorescence was visualized with an Olympus IX50 with LC
Plan Fl 40 /0.60 Ph2 or LC Ach 20 /0.4 PhC objective. Photomicro-
graphs were acquired digitally using the DP Controller for a cooled
charge coupled device camera (DP70; Olympus). Controls with secondary
antibodies only or with one primary along with one or both secondary an-
tibodies accompanied each experiment. NIH Image v1.62 was used to
measure neurite lengths using a stage micrometer scale provided by the
microscopy image laboratory (University of Michigan). ImageJ was used
to perform cell counts on digital images.
Statistical analysis
p-values were calculated using the two-sided t test.
Online supplemental material
Supplemental data provide information on primer and PCR conditions
used in Figs. 1 and 2 and methods to test the efficacy and specificity of
shRNA constructs and measurements of JNK and p38 activity. Fig. S1
shows the efficacy and specificity of Gab2 and Gab3 shRNA constructs.
Fig. S2 shows JNK and p38 kinase activities during RA-induced cell
death. Online supplemental material is available at http://www.jcb.org/
cgi/content/full/jcb.200505061/DC1.
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